FDA Warning Letter — Hikma Pharmaceuticals USA INC.

Case 53122 — FEI 1510690

The FDA took a Warning Letter action against Hikma Pharmaceuticals USA INC. on Mar 30, 2009 (Columbus, OH). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Hikma Pharmaceuticals USA INC.
Date
Mar 30, 2009
Fiscal Year
2009
Product Type
Drugs
Center
CDER
Location
Columbus, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.